Double-blind clinical trial of domiodol vs S-carboxymethylcysteine in chronic obstructive lung disease.
The results of a double-blind trial on the clinical and functional effects induced by domiodol and S-carboxymethylcysteine (SCMC) on 40 patients with chronic obstructive lung disease are discussed. Although the therapeutic effects of the two drugs showed no statistical differences both substances had a positive effect on all patients. In general domiodol took effect more rapidly, a feature that is often very convenient.
D000328:Adult; D000368:Aged; D002233:Carbocysteine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003545:Cysteine / Q000031:analogs & derivatives*; D004148:Dioxolanes / Q000627:therapeutic use*; D004149:Dioxoles / Q000627:therapeutic use*; D004311:Double-Blind Method; D005100:Expectorants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation
D004148:Dioxolanes; D004149:Dioxoles; D005100:Expectorants; D002233:Carbocysteine; C027858:domiodol; D003545:Cysteine